Darling Ingredients Inc (DAR)

Investment Committee Summary

Investment Thesis

Darling Ingredients develops, produces and sells natural ingredients derived from edible and non-edible bio-nutrients — a processing business whose earnings are a spread between what it pays for raw material and what its output fetches. Volume is comparatively steady; the margin is not, which is why an operating margin near 16% (reported GAAP, TTM to Jun 2026) says less about this business than the direction of that spread does. At $61.06 on 13 October 2026, roughly 14 times forward earnings and close to the top of a 52-week range whose low is less than half the current price, the market has already paid for a substantial margin recovery. The engine's twelve-month target of $63.55 sits near spot, but triangulation across the fuller valuation work lands far lower at $49.52, leaving the shares trading rich to that anchor by -19% at a HOLD — one of the widest gaps in this group between the short-horizon target and the underlying valuation, and a reader should weight the latter. The decisive variable is the processing spread, which commodity and feed-cost markets set rather than management. The single most damaging risk is a spread reset with net debt of ~$4.2B attached: leverage against a volatile margin is what turns a cyclical trough into a structural problem.

Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.

The dashboard below is the whole argument on one page: spot ($61.06) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Anti-Thesis (The Real Bear Case)

The bear case is leverage applied to a commodity spread. Raw-material cost and output price are set in different markets and do not move together, so when input prices hold while output prices fall the entire spread disappears, and fixed plant costs turn a margin squeeze into an operating loss at the segment level. That requires no unusual event in agricultural processing — a good harvest, a soft protein cycle, or added capacity coming online will do it. Against net debt of ~$4.2B and no dividend, the equity absorbs the whole swing, and the covenant arithmetic tightens precisely when earnings fall, forcing asset sales or equity issuance at the worst moment. The multiple then de-rates as the market stops treating trough earnings as temporary. With the shares near the top of their 52-week range the entry price offers no protection, and the structural path — a permanent reset in processing margins — targets a price far below the 52-week low.

Key Debate

Gross Margin explains 55% of Monte Carlo outcome variance — the single variable that decides which side is right.

What the Market Is Pricing In

At the current price, the market pays 9.0× consensus forward EPS, vs the house DCF terminal 13.0×, and a peer median 14.5×. The house DCF sits 51% below spot, so the market is pricing in more than the house case — roughly 4.2pp of revenue CAGR.

Variant perception: the house view is below-consensus, and the thesis is primarily multiple-driven.

Scenario Analysis

The scenario tree spans a structural 'Structural — Crush / Protein Margin Reset' downside ($22.64) to a 'Spike — Supply Dislocation' bull case ($131); the probability-weighted blend (PWEV $63.55) is +4% versus spot.

SBC charge: scenario targets are gross per-share prices; the PWEV is reduced by one year of stock-based-compensation dilution (1.5% of shares, on SBC ≈ 0% of revenue), trimming the gross PWEV of $64.50 to $63.55 (-1.5%). SBC is charged once, as dilution — never also deducted from FCF.

Scenario rationale — the driver path behind every target:

• Structural — Crush / Protein Margin Reset (22%, $22.64). Structural impairment — crush / protein margin reset: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
• Cyclical Margin Trough (18%, $40.31). Cyclical downturn — ag-processing crush margins / protein cycle + commodity & feed costs weakens for 1–2 years before normalising.
• Base — Mid-Cycle Crush / Protein Margins (32%, $65.44). Mid-cycle — normalised ag-processing crush margins / protein cycle + commodity & feed costs; disciplined capital allocation; steady returns.
• Upcycle — Tight Margins (20%, $104). Upside — tight crush / protein margins lifts earnings above mid-cycle; the multiple expands modestly.
• Spike — Supply Dislocation (8%, $131). Upside tail — sustained tight conditions or a structural re-rate on tight crush / protein margins.

Valuation Triangulation

Four weighted anchors — an intrinsic dcf, a scenario-weighted pwev, a monte carlo median (student-t + regime switching) and a peer p/e re-rate — read them with their basis in mind. The Monte Carlo, the scenario PWEV, any DCF's exit-multiple terminal and any peer re-rate key off a market multiple, so they are not independent; only a DCF's explicit-period cash flows are multiple-free, and its terminal usually carries most of its value. The discipline is to read the spread, not to treat four numbers as four independent votes.

The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name sum-of-parts is not computed, so 15% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way. The company-lever row in the Sensitivity section is an illustrative EBIT × multiple value, not a sum-of-parts anchor.

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

Rating vs blend — the key debate. The rating tracks the multiple-discipline fair value (Monte Carlo $43.83 + scenario PWEV $63.55, ≈ spot); the weighted blend $49.52 (-19%) sits below it because the exit-multiple DCF ($30.17) is materially more conservative than the market multiple. Whether the current multiple is justified is the central question for this name — and the principal downside risk to the rating.

Monte Carlo — the outcome distribution

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $43.83 and 30% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (55% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.

DCF — explicit-period cash flows with an exit-multiple terminal

A 5-year cash-flow path discounted at a WACC of 9.0%, plus a terminal value of final-year FCF × 13.0x — a terminal multiple equal to 0.85 × the base multiple that the Monte Carlo and the scenario tree also use → $30.17. The terminal value is 69% of enterprise value, so this anchor moves with the multiple assumption. Weighted 29% in the blend; its exit-multiple terminal ties it to a market multiple, so it is not an independent vote.

Peer benchmarking — relative value

Against its 3 peers in the same GICS sub-industry, re-rating to their median forward multiple (P/E 14.5x) implies $62.48. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 14% so market sentiment does not set the fair value.

Across all anchors the spread is 153% of the median — wide (genuine disagreement — the blend carries low valuation confidence).

Sensitivity

DCF/share — WACC × terminal multiple

DCF/share — revenue CAGR Δ × model op-margin Δ (Δ applied to the DCF's house margin path)

Tornado — DCF/share swing by driver (widest first)

Company lever — value at the base multiple vs Agricultural Products & Protein multiple (base 15.0x)

Illustrative: segment EBIT × multiple, plus net cash, over basic shares — it does not enter the triangulated fair value.

Peer Quality & Weighting

Quality-weighted forward P/E: 14.3× (simple median 14.5×). Direct peers count 100%, segment 50%, broad 25%.

Historical-range cross-check: 52-week range $29.15–$69.98, centre $45.20 (-26% vs spot); spot sits at the 78th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

That ratio is (triangulated FV ÷ price − 1) ÷ (1 − 'Structural — Crush / Protein Margin Reset' target ÷ price). 'Structural — Crush / Protein Margin Reset' ($22.64, probability 22%) is the lowest-target scenario in the tree, taken gross of SBC dilution. With a leg missing the ratio is withheld rather than computed from a magnitude. Bull case (Spike — Supply Dislocation): $131.

Company Overview & Business Model

Darling Ingredients Inc — CONSUMER DEFENSIVE · PACKAGED FOODS. Darling Ingredients Inc. develops, produces and sells natural ingredients from edible and non-edible bio-nutrients. The company is headquartered in Irving, Texas.

Company description as supplied by Alpha Vantage; not checked against the company's filings.

How it makes money.

† Model margin = gross margin − the opex ratio calibrated so the Monte Carlo median EPS meets the EPS target; it is not a reported operating margin.

Reported operating margin (GAAP): 6.5% for the fiscal year ended 2025-12-31; 15.9% TTM to 2026-06-30 (Alpha Vantage INCOME_STATEMENT).

Edge. Narrow moat — inferred from a 16% (reported GAAP, TTM to Jun 2026) operating margin and the agricultural products & protein business model. Some pricing power / share stability; terminal multiple near the market.

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

For comparison, the company's reported GAAP operating margin was 6.5% for the fiscal year ended 2025-12-31; 15.9% TTM to 2026-06-30 (Alpha Vantage INCOME_STATEMENT).

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Capital intensity & shareholder returns (ESTIMATE)

Structural risk vs optionality (INFERENCE)

Industry Context — Consumer Staples — Ag

This name sits in the Consumer Staples — Ag cluster as a agricultural products & protein name. ag-processing crush margins / protein cycle + commodity & feed costs. Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.

Value chain: DAR (agricultural products & protein) · INGR (agricultural products & protein)

Mapping note: name-level 'Structural — Crush / Protein Margin Reset' (22%) + 'Cyclical Margin Trough' (18%) map to cluster Crush / Protein Margin Reset (40%); name-level 'Upcycle — Tight Margins' (20%) + 'Spike — Supply Dislocation' (8%) map to cluster Tight-Margin Upcycle (28%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.

On the cluster's key downside — Crush / Protein Margin Reset — this name implies 40% vs the cluster house view of 40% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.

Structure: Shared State — The Consumer Staples — Ag cycle is the shared macro driver. Driver — ag-processing crush margins / protein cycle + commodity & feed costs. Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).

Balance Sheet & Liquidity

Balance-sheet data as of 2025-12-31 (Alpha Vantage).

Capital Allocation

Free-Cash-Flow Quality

Accounting quality: SBC 0% of revenue.

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q1): management +0.31 vs analyst floor +0.02 → delta +0.30 (n=34 mgmt / 24 Q&A; 25th pctile across the S&P book, z -0.8).

Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.

News (last 365d, 347 articles): avg ticker sentiment +0.24 (bullish 35% / bearish 3%)

Consensus & Market Expectations

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Catalyst Calendar

• 2026-10-29 (~17d) — Quarterly earnings — est. EPS $1.86 (AV EARNINGS_CALENDAR)

Forecast Track Record

• EPS surprise: beat 50% of the last 8 quarters; average surprise +0.8%.

Catalyst Timeline

5 catalysts in the next 90 days (of 12 tracked). Importance 1–3; confidence 0–1.

_Sources: extended.catalysts, data/catalysts/.json, data/catalysts/macro.json, AV DIVIDENDS, opex 3rd-Friday calc.

Scenario Macro & Key Risks

Decision Rules (Machine-Checked)

Stance: Hold — 0 bullish / 0 bearish / 0 caution rules triggered of 5 evaluable (1 lacked data).

Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is what the model's own rules read on this name; it does not modify the published research rating, and it is not personal financial advice.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

• Organic revenue growth / order backlog < flat-to-negative for two consecutive quarters (2 consecutive prints). Sustained demand rollover breaks the base case toward the recession scenario.
• FY revenue ($B) < 6.35 (next reported fiscal year). (rationale withheld pending re-authoring — frozen figure or verdict)
• Probability-weighted fair value (PWEV) at the next re-run < 61.06 (any scheduled re-run). (rationale withheld pending re-authoring — frozen figure or verdict)

Fact / Inference / Speculation

• FACT: Spot $61.06; 52-week range $29.15–$69.98; engine rating HOLD; house target $63.55 (+4%). (source: Alpha Vantage 2026-10-12, 13 October 2026)
• INFERENCE: Triangulated FV $49.52 (-19% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the DCF anchor sits below the multiple-discipline core.
• SPECULATION: At current prices the embedded bet is that Gross Margin keeps surprising favourably — an operating call the next two prints will test.

Conviction Score

Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.

40.6/100 (confidence band 32.9–48.3), 7th percentile of 928 covered names (as of 2026-10-12). Weighted composite under config ros-1.21.0 — every component and its inputs below.

Score history: 44.0 → 43.9 → 44.2 → 43.9 → 44.3 → 44.2 → 44.8 → 44.8.

Probability-Weighted Return Profile

Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.

The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.

Expected Alpha

Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).

A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.

Probability Cross-Checks

Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.

Authored set: 5 scenarios, probabilities summing to 1.0, mean target $64.5.

Flagged for review: internal coherence (authored mass vs Monte Carlo). A flag marks a disagreement worth understanding — it does not imply either side is wrong.

Factor Exposures

Cross-sectional percentiles over 928 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.

Market interaction: correlation vs SPY +0.29, vs QQQ +0.22 (trailing ~1y daily returns).

Rating Bridge

Rating = HOLD because:

• Probability-weighted scenario value implies +4% vs spot
• Monte Carlo median implies -28% vs spot
• DCF fair value (exit-multiple terminal) implies -51% vs spot — but this is terminal-value sensitive (exit-multiple $30.17 vs Gordon $38.53, 28% apart), so it carries less weight
• Bear case (Structural — Crush / Protein Margin Reset) downside is -63% vs spot
• Net: the valuation anchor itself sits 18.9% below spot, so there is no reward leg to weigh against the bear case and the reward-to-risk ratio is withheld rather than computed off a negative upside. The rating is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.

Model Appendix

DCF — line items

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 6% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 9.0% · Σ PV(FCF) $3B + PV(terminal) $6B = EV $9B; − net debt $4.2B → equity $5B ÷ diluted shares $0.16B = $30.17/share (exit-multiple terminal).

• Gordon terminal → $38.53/share — a single-point perpetual-growth cross-check at g = 2.5% (one growth rate, not a range; it is not in the blend).
• Incremental ROIC on the forecast capex ≈ 4% vs WACC 9.0% → below WACC — the incremental build is value-dilutive.

Peer set

Implied prices at the peer medians: same-sub-industry median fwd P/E → $62.48; EV/Rev → $-3.42.

Weighted fair-value math

Model Calibration Caveats

Raised by the model's own checks on its run of 13 October 2026 (prices as of 2026-10-12). They concern how the model was calibrated, not the company; read the figures they touch with them in mind.

• The Monte Carlo's median earnings per share ($3.32) is 23% away from the EPS target the model was calibrated to ($4.30). The model's operating-cost ratio (operating expenses as a share of revenue) could not be tuned close enough, so the Monte Carlo value rests on earnings that do not match the target.

Assumption Register

Sensitivity-ranked drivers (widest fair-value swing first): Model op margin ±3pp (24.0); Terminal × ±15% (12.0); Revenue CAGR ±3pp (11.0); Capex intensity ±15% (9.0); WACC ±1pp (5.0).

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Research Provenance

Load-Bearing Assumptions

DCF: WACC 9.0%, terminal multiple 13×, FY+5 revenue $7B. Triangulation leans 36% on PWEV, 29% on DCF, 21% on the Monte Carlo median, 14% on peer-implied value.